259 related articles for article (PubMed ID: 16179269)
1. Is liver disease a threat to patients with metabolic disorders?
Marchesini G; Forlani G; Bugianesi E
Ann Med; 2005; 37(5):333-46. PubMed ID: 16179269
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease and the metabolic syndrome.
Marchesini G; Babini M
Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
[TBL] [Abstract][Full Text] [Related]
3. Review article: steatosis, the metabolic syndrome and cancer.
Bugianesi E
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():40-3. PubMed ID: 16225471
[TBL] [Abstract][Full Text] [Related]
4. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
Younossi ZM; McCullough AJ
Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
7. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
[TBL] [Abstract][Full Text] [Related]
8. Chronic liver disease in diabetes mellitus.
Amarapurkar D; Das HS
Trop Gastroenterol; 2002; 23(1):3-5. PubMed ID: 12170918
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for pure steatosis in alcoholic patients.
Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
[TBL] [Abstract][Full Text] [Related]
11. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
Haffner SM
Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
[TBL] [Abstract][Full Text] [Related]
12. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.
Trombetta M; Spiazzi G; Zoppini G; Muggeo M
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():24-7. PubMed ID: 16225467
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and NASH.
Marchesini G; Marzocchi R
Clin Liver Dis; 2007 Feb; 11(1):105-17, ix. PubMed ID: 17544974
[TBL] [Abstract][Full Text] [Related]
14. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease: defining a common problem.
Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
Tarantino G; Saldalamacchia G; Conca P; Arena A
J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
[TBL] [Abstract][Full Text] [Related]
17. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
Fan JG
J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
[TBL] [Abstract][Full Text] [Related]
18. Impact of diabetes on the severity of liver disease.
Hickman IJ; Macdonald GA
Am J Med; 2007 Oct; 120(10):829-34. PubMed ID: 17904449
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic steatohepatitis and metabolic syndrome.
Machado M; Cortez-Pinto H
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
[TBL] [Abstract][Full Text] [Related]
20. Fatty liver: a novel component of the metabolic syndrome.
Kotronen A; Yki-Järvinen H
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):27-38. PubMed ID: 17690317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]